千金汤加味治疗痰热壅肺型慢性阻塞性肺疾病急性加重期患者临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Modified Qianjin Decoction for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease of Phlegm-Heat Obstructing the Lung Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察千金汤加味治疗痰热壅肺型慢性阻塞性肺疾病(COPD) 急性加重期患者的疗效。方 法:筛选74 例痰热壅肺型COPD 急性加重期患者,按随机数字表法分为观察组与对照组各37 例。对照组给予 西医常规治疗,观察组在西医常规治疗基础上加用千金汤加味治疗。治疗2 周后,比较2 组临床疗效,以及治 疗前后改良版英国医学研究委员会呼吸问卷(mMRC) 评分、肺功能指标[第1 秒用力呼气量(FEV1) 和FEV1 占总用力呼气量比例(FEV1/FVC) ]水平、中医证候评分、炎症因子[血清C-反应蛋白(CRP)、降钙素 原(PCT)、肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6) ]水平。结果:治疗后,观察组总有效率为 94.59%,对照组为72.97%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组mMRC、CAT 评分均较治 疗前下降(P<0.05),且观察组mMRC、CAT 评分均低于对照组(P<0.05)。治疗后,2 组FEV1 和FEV1/FVC 水平均较治疗前升高(P<0.05),且观察组2 项指标均高于对照组(P<0.05)。治疗后,2 组中医证候评分均 较治疗前降低(P<0.05),且观察组中医证候评分低于对照组(P<0.05)。治疗后,2 组血清CRP、PCT、 TNF-α、IL-6 水平均较治疗前降低(P<0.05),且观察组4 项炎症因子水平均低于对照组(P<0.05)。结论: 千金汤加味治疗痰热壅肺型COPD 急性加重期患者疗效确切,可抑制机体炎症反应,有效改善患者肺功能、呼 吸困难程度及中医证候。

    Abstract:

    Abstract: Objective: To observe the curative effect of modified Qianjin Decoction on patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) of phlegm- heat obstructing the lung type. Methods: A total of 74 cases of patients with acute exacerbation of COPD of phlegm- heat obstructing the lung type were screened and divided into the observation group and the control group according to the random number table method,with 37 cases in each group. The control group was treated with routine western medicine,and the observation group was additionally treated with Qianjin Decoction based on routine treatment of western medicine. After 2 weeks of treatment,Respiratory Questionnaire of modified Medical Research Council (mMRC) scores, levels of lung function indexes [forced expiratory volume in the first second (FEV1) and ratio of FEV1 to total forced expiratory volume (FEV1/FVC)],traditional Chinese medicine (TCM) syndrome scores, levels of inflammatory factors [C- reactive protein (CRP), procalcitonin (PCT),tumor necrosis factor-α (TNF-α),and interleukin-6 (IL-6) in serum] before and after treatment as well as the clinical effects were compared between the two groups. Results: After treatment,the total effective rate was 94.59% in the observation group and 72.97% in the control group, the difference being significant (P<0.05). After treatment,the scores of mMRC and CAT in the two groups were decreased when compared with those before treatment (P<0.05),and the scores of mMRC and CAT in the observation group were lower than those in the control group (P<0.05). After treatment,the levels of FEV1 and FEV1/FVC in the two groups were increased when compared with those before treatment (P< 0.05),and the two indexes in observation group were higher than those in the control group (P<0.05). After treatment, TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05), and the TCM syndrome score in the observation group was lower than that in the control group (P<0.05). After treatment,the levels of CRP,PCT,TNF-α,and IL-6 in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of the four inflammatory factors in the observation group were lower than those in the control group (P<0.05). Conclusion: Modified Qianjin Decoction has a definite curative effect effective in treating patients with acute exacerbation of COPD of phlegm- heat obstructing the lung type. It can inhibit inflammatory responses of the body,and effectively improve the lung function,dyspnea degree and TCM syndromes.

    参考文献
    相似文献
    引证文献
引用本文

杜珍奇,李向东,邵文龙.千金汤加味治疗痰热壅肺型慢性阻塞性肺疾病急性加重期患者临床研究[J].新中医,2024,56(4):20-24

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-02-28
  • 出版日期:
文章二维码